| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 1163-36-6 | 鹽酸氯咪唑; 1-[(4-氯苯基)甲基]-2-(吡咯烷-1-基甲基)苯并咪唑鹽酸鹽 | Clemizole hydrochloride; 1-[(4-Chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzoimidazole hydrochloride |  | C19H21Cl2N3 | 詳情 | 供應(yīng)商 |
| 59338-87-3 | 鹽酸阿立必利; 6-甲氧基-N-[(1-丙-2-烯基吡咯烷-2-基)甲基]-2H-苯并三唑-5-甲酰胺鹽酸鹽 | Alizapride hydrochloride; 6-Methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2H-benzotriazole-5-carboxamide hydrochloride |  | C16H22ClN5O2 | 詳情 | 供應(yīng)商 |
| 59338-93-1 | 阿立必利; N-(1-烯丙基-2-吡咯烷基甲基)-6-甲氧基-1H-苯并三唑-5-甲酰胺 | Alizapride; N-(1-Allyl-2-pyrrolidinylmethyl)-6-methoxy-1H-benzotriazole-5-carboxamide |  | C16H21N5O2 | 詳情 | 供應(yīng)商 |
| 105379-24-6 | HBPyU; (苯并三氮唑-1-基氧基)二吡咯烷碳鎓六氟磷酸鹽 | (Benzotriazol-1-yloxy)dipyrrolidinocarbenium hexafluorophosphate; HBPyU; O-(Benzotriazol-1-yl)-N,N,N',N'-bis(tetramethylene)uronium hexafluorophosphate |  | C15H20F6N5OP | 詳情 | 供應(yīng)商 |
| 128625-52-5 | PyBOP; 六氟磷酸苯并三唑-1-基-氧基三吡咯烷基磷 | PYBOP; Benzotriazole-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate |  | C18H28F6N6OP2 | 詳情 | 供應(yīng)商 |
| 132036-42-1 | 1-吡咯烷基(4,5,6,7-四氫-1H-苯并咪唑-6-基)甲酮鹽酸鹽 | 1-Pyrrolidinyl(4,5,6,7-tetrahydro-1H-benzimidazol-6-yl)methanone hydrochloride; 1-[(4,5,6,7-Tetrahydro-1H-benzimidazol-5-yl)carbonyl]pyrrolidine monohydrochloride |  | C12H18ClN3O | 詳情 | 供應(yīng)商 |
| 133099-04-4 | 達(dá)非那新; 2-[1-[2-(2,3-二氫苯并呋喃-5-基)乙基]-3-吡咯烷基]-2,2-二苯基乙酰胺 | Darifenacin; 3-Pyrrolidineacetamide,1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-a,a-diphenyl-, (S)-; (3S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-pyrrolidine; (S)-(-)-3-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine; (S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-a,a-diphenyl-3-pyrrolidineacetamide; (S)-3-(1-Carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine; Darifenacin; UK 88525 |  | C28H30N2O2 | 詳情 | 供應(yīng)商 |
| 133099-07-7 | 氫溴酸達(dá)非那新; {1-[2-(2,3-二氫苯并呋喃-5-基)乙基]-3-吡咯烷基}-2,2-二苯基乙酰胺氫溴酸鹽 | Darifenacin hydrobromide; {1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide |  | C28H30N2O2.HBr | 詳情 | 供應(yīng)商 |
| 173937-91-2 | 阿曲生坦; (2R,3R,4S)-4-(1,3-苯并二氧戊環(huán)-5-基)-1-[2-(二丁基氨基)-2-氧代乙基]-2-(4-甲氧基苯基)吡咯烷-3 | Atrasentan; (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid |  | C29H38N2O6 | 詳情 | 供應(yīng)商 |
| 195733-43-8 | 鹽酸阿曲生坦; (2R,3R,4S)-4-(1,3-苯并二氧戊環(huán)-5-基)-1-[2-(二丁基氨基)-2-氧代乙基]-2-(4-甲氧基苯基)吡咯 | Atrasentan hydrochloride; (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride |  | C29H39ClN2O6 | 詳情 | 供應(yīng)商 |
| 687603-66-3 | 1-(1,3-苯并二氧雜環(huán)戊-5-基)-2-(1-吡咯烷基)-1-戊酮 | 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone; 1-(3,4-Methylenedioxyphenyl)-2-pyrrolidinylpentan-1-one |  | C16H21NO3 | 詳情 | 供應(yīng)商 |
| 7724-48-3 | 2,3-二氫-1H-吡咯并[1,2-A]苯并咪唑 | 2-a]benzimidazole, 2,3-dihydro-1H-Pyrrolo[1; 1H-Pyrrolo[1,2-a]benzimidazole,2,3-dihydro- |  | C10H10N2 | 詳情 | 供應(yīng)商 |
| 144223-32-5 | 1-(2-吡咯羰基)苯并三唑 | Methanone,1H-benzotriazol-1-yl-1H-pyrrol-2-yl-; 1H-Benzotriazole,1-(1H-pyrrol-2-ylcarbonyl)- (9CI) |  | C11H8N4O | 詳情 | 供應(yīng)商 |
| 19213-23-1 | (1-吡咯烷基甲基)苯并三唑 | 1H-Benzotriazole,1-(1-pyrrolidinylmethyl)-; (1-PYRROLIDINYLMETHYL)BENZOTRIAZOLE 97&; (1-PYRROLIDINYLMETHYL)BENZOTRIAZOLE, 97% , MIXTURE OF BT1 AND BT2 ISOMERS; (1-pyrrolidinylmethyl)benzotriazole, mixture of bt1 and bt2 isomers |  | C11H14N4 | 詳情 | 供應(yīng)商 |
| 18877-34-4 | (S)-(+)-2,3-二氫-1H-吡咯并[2,1-c][1,4]苯并二氮卓-5,11(10H,11aH)-二酮 | 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,2,3-dihydro-, (11aS)-; 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,2,3-dihydro-, (S)-; 5H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione,1,2,3,11a-tetrahydro-, L- (8CI) |  | C12H12N2O2 | 詳情 | 供應(yīng)商 |
| 1012884-46-6 | 11-氯-2,3-二氫-2-甲基-1H-二苯并[2,3:6,7]氧雜卓并[4,5-c]吡咯-1-酮 | 1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one,11-chloro-2,3-dihydro-2-methyl- |  | C17H12ClNO2 | 詳情 | 供應(yīng)商 |
| 143112-52-1 | (S)-(+)-4-硝基-7-(3-氨基吡咯啶)-2,1,3-苯并噻二唑 | 3-Pyrrolidinamine,1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (3S)-; 3-Pyrrolidinamine,1-(7-nitro-4-benzofurazanyl)-, (S)-; 2,1,3-Benzoxadiazole, 3-pyrrolidinaminederiv.; (S)-(+)-4-(3-Aminopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole |  | C10H11N5O3 | 詳情 | 供應(yīng)商 |
| 143112-51-0 | (R)-(-)-4-硝基-7-(3-氨基吡咯啶)苯并呋咱 | 3-Pyrrolidinamine,1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (3R)-; 3-Pyrrolidinamine,1-(7-nitro-4-benzofurazanyl)-, (R)-; 2,1,3-Benzoxadiazole, 3-pyrrolidinaminederiv.; (+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole; 3-Pyrrolidinamine, 1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (R)- |  | C10H11N5O3 | 詳情 | 供應(yīng)商 |
| 13473-53-5 | 2 - (2-氨乙基)-3- (4-氯苯基)- 3 -羥基苯并[C]吡咯酮鹽酸 | 2-(2-Aminoethyl)-3-(4-chlorophenyl)-3-hydroxyphthalimidine Hydrochloride; 2-(2-Aminoethyl)-3-(4-chlorophenyl)-3-hydroxyphthalimidine Hydrochloride; 2-(2-Aminoethyl)-3-(4-chlorophenyl)-3-hydroxyphthalimidine Hydrochloride (Mazindol Metabolite) | 無(wú) | C16H16Cl2N2O2 | 詳情 | 供應(yīng)商 |
| 65576-45-6 | 反式-5-氯-2,3,3A,12B-四氫-2-甲基-1H-二苯并[2,3:6,7]氧雜卓并[4,5-C]吡咯 | trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole; trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole; Asenapine; (3aR,12bR)-rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole; 1H-Dibenz(2,3:6,7)oxepino(4,5-C)pyrrole, 5-chloro-2,3,3A,12B-tetrahydro-2-methyl-, (3ar,12br)-rel-; 1H-Dibenz(2,3:6,7)oxepino(4,5-C)pyrrole, 5-chloro-2,3,3A,12B-tetrahydro-2-methyl-, trans-; Asenapine [inn:ban]; Einecs 265-829-4; Unii-jkz19V908o |  | C17H16ClNO | 詳情 | 供應(yīng)商 |